Live Breaking News & Updates on Roche Pharma Partnering
Stay updated with breaking news from Roche pharma partnering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Roche Holding AG (OTCMKTS:RHHBY – Get Free Report) have earned a consensus rating of “Hold” from the seven analysts that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and two have issued a buy recommendation on the company. […] ....
Tower Bridge Advisors purchased a new position in Roche Holding AG (OTCMKTS:RHHBY – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 82,150 shares of the company’s stock, valued at approximately $2,811,000. A number of other hedge […] ....
Roche (RHHBY) announced the European Commission has granted marketing authorisation for Tecentriq SC, a PD-L1 cancer immunotherapy for subcutaneous injection. The authorisation applies to all approved indications of Tecentriq IV. ....
Sky Investment Group LLC trimmed its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY – Free Report) by 6.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,593 shares of the company’s stock after selling 3,580 shares during […] ....